SAN DIEGO (BUSINESS WIRE) Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will host its Investor and Analyst Day on Tuesday, December 12, 2023.Members of Ligand’s senior management team will provide an update on the company’s strategy and portfolio as well as a multi-year financial outlook and a 2024 guidance p.
Ligand Pharmaceuticals Incorporated will host its Investor and Analyst Day on Tuesday, December 12, 2023.
Members of Ligand’s senior management team will provide an update on the company’s.